Philip McCarthy, MD, of Roswell Park Comprehensive Cancer Center, Buffalo, NY, discusses two Phase III multiple myeloma (MM) transplantation studies that have been performed: EMN02 (NCT01208766) and BMT CTN 0702 (NCT01109004). Prof. McCarthy highlights how both studies had similar designs, but yielded different results. This video was recorded at the 1st European Myeloma Network Meeting, in Turin, Italy.
Transplant trials in myeloma: EMN02 and BMT CTN 0702
